Latest Capital Equipment News

IperionX has won up to US$6.6 million from the US Department of War to scale production of ballistic-grade titanium plate and military components, aiming to reduce reliance on imports and strengthen domestic supply chains.

Trajan Group Holdings reports steady market demand and successful cost initiatives in H2 FY26 but warns of a $4 million revenue hit from Australian dollar appreciation.

Cyprium Metals has made substantial progress on its Nifty Copper Complex restart, targeting copper cathode production by September 2026 while securing A$41 million to fuel exploration and growth.

CurveBeam AI reported stable device orders but faces regulatory delays for FDA and China clearances, while securing a A$4 million investment from WEGO Orthopaedics and advancing clinical collaborations with robotic surgery systems.

CONNEQT Health’s Pulse device sales surged to a $7 million annualised run-rate despite a temporary supply hiccup, while the company manages a tight cash runway supported by new R&D loans and related-party funding.

Imricor Medical Systems advanced FDA clearances and expanded clinical trials in Q1 CY26, positioning for commercial growth despite higher operating cash outflows.

333D Ltd (ASX:T3D) reversed its prior quarter’s cash outflow to report a $71,505 positive operating cash flow for March 2026, driven by growing healthcare digital asset contracts and a strategic Bitcoin holding. The company also deployed $95,800 post-quarter to scale its healthcare-focused platform.

Compumedics maintains robust sales momentum but faces FY26 revenue timing challenges due to MEG installation delays and a cautious Somfit D rollout. The company expects solid year-on-year growth and positions for improved execution in FY27.

Freehill Mining’s aggregate materials sales surged in March, with quarterly sales up 60%, while the company prioritises mine planning and permitting for its Blanco y Negro copper-gold project.

XRF Scientific posted a 13.8% jump in March quarter revenue to $15.8 million, led by strong international sales and new product shipments. The newly operational India office marks a strategic expansion, setting the stage for further growth.

Galan Lithium has finished Phase 1 construction at its Hombre Muerto West project in Argentina and is set to begin lithium production in the first half of 2026, marking a key milestone toward becoming an ASX-listed producer.

CONNEQT Health reported a 40% revenue increase to $2.28 million for the half-year ending December 2025, driven by strong sales of its CONNEQT Pulse device and early subscription uptake. Despite narrowing its net loss by 14%, the company continues to navigate operational restructuring and funding challenges as it pivots towards a recurring revenue model.